“A significant proportion” of MS patients report having either “stopped or reduced” their use of prescription medications after initiating cannabis therapy.
Region: CT
Researchers concluded, “The majority of patients in our study felt that medical cannabis was equivalent or superior in efficacy to other medications.”
Forty-nine percent of respondents reported having experimented with either CBD or other cannabinoid products for migraine.
"In the face of the challenge of recovering from the COVID-19 pandemic, legalization offers a path to a stronger recovery."
"Well-established markets may have crowded-out use of riskier, informally sourced e-liquids."
"[P]atients who obtained medical marijuana showed a reduction in median six-month hospital admissions compared with the patients who did not."
Patients with persistent chronic pain conditions are now eligible to medical cannabis therapy.
New Haven, CT: Sickle cell disease (SCD) patients who consume cannabis on a daily basis…